Jan 8, 2026, 11:29 GMT+7
By Bharath Rajeswaran and Vivek Kumar M
Reuters - Indian shares were headed for a fourth straight session of declines on Thursday amid cautious sentiment, with U.S. tariff worries and foreign fund outflows overshadowing optimism over earnings growth.
The Nifty 50fell 0.18% to 26,093.35, while the Sensextraded 0.13% lower at 84,847.3, as of 9:55 a.m. IST.
Fifteen of the 16 major sectors fell. The broader small-capsand mid-capsslipped 0.2% and 0.4%, respectively.
The Nifty 50 index has fallen 0.7% in the last three sessions, and the Sensex lost 0.9%, after U.S. President Donald Trump warned of higher tariffs on Indian goods over Russian oil purchases, even as New Delhi seeks a trade deal with Washington.
The U.S. has already imposed tariffs of up to 50% on Indian goods, with half of those penalties tied to New Delhi's Russian crude imports.
Meanwhile, foreign investors sold Indian shares worth 15.28 billion rupees ($170.26 million) on Wednesday, provisional data showed. They have offloaded $694 million worth of shares so far in January after record outflows in 2025.
"Geopolitics and global trade have cast a shadow of chronic risk aversion for equity markets," said analysts led by Abhishek Saraf of Motilal Oswal Financial Services.
The conclusion of the long-pending India-U.S. bilateral trade deal will be a key catalyst for an upside move in Indian markets, they added.
Metal indexdeclined 1.9% with all 15 constituents logging losses, as the global metals rally lost steam. The sectoral sub-index had hit a record high on Tuesday.
IT indexfell 1% after gaining 2.4% in the last two sessions.
Among stocks, Gland Pharmaclimbed 2% after receiving the U.S. drug regulator's approval for Olopatadine solution aimed at treating ocular itching and allergic conjunctivitis.
Balaji Aminesjumped 9% after the Maharashtra government granted an eligibility certificate for unit expansion, making the company eligible for industrial subsidies worth 2.58 billion rupees.
($1 = 89.7450 Indian rupees)
Sumber : Reuters
作者:indopremier_id,文章来源indopremier_id,版权归原作者所有,如有侵权请联系本人删除。
风险提示:本文所述仅代表作者个人观点,不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证,对于基于该内容所采取的任何行为,不承担任何责任,除非另有书面明确说明。
喜欢的话,赞赏支持一下

暂无评论,立马抢沙发